RVL Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
24 Oct 23 | SellUS$20,164 | Altchem Limited | Company | 4,941,101 | US$0.0042 | |
20 Oct 23 | SellUS$580,147 | Altchem Limited | Company | 14,122,659 | US$0.046 | |
18 Oct 23 | SellUS$221,031 | Altchem Limited | Company | 3,421,537 | US$0.065 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 180,566 | 0.162% |
Private Companies | 1,182,243 | 1.06% |
Individual Insiders | 3,080,239 | 2.76% |
Hedge Funds | 10,648,000 | 9.56% |
General Public | 96,314,995 | 86.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,648,000 | US$10.6 | 0% | no data | |||
2,338,242 | US$2.3 | 0% | no data | |||
1,182,243 | US$1.2 | -95% | no data | |||
506,521 | US$0.5 | 0% | no data | |||
180,566 | US$0.2 | 0% | no data | |||
162,864 | US$0.2 | 0% | no data | |||
50,055 | US$0.05 | 0% | no data | |||
22,557 | US$0.02 | 0% | no data |